1 / 2

ARS Question #1

ARS Question #1. Which treatment for MM should be avoided in patients wishing to pursue autologous peripheral blood stem cell transplant but is often used in elderly? A. Bortezomib B. Lenalidomide C. Melphalan D. Prednisone . ARS Question #2.

elvina
Télécharger la présentation

ARS Question #1

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. ARS Question #1 • Which treatment for MM should be avoided in patients wishing to pursue autologous peripheral blood stem cell transplant but is often used in elderly? A. Bortezomib B. Lenalidomide C. Melphalan D. Prednisone

  2. ARS Question #2 • According to the most current clinical trial data, which of the approved treatments for elderly patients with newly diagnosed CLL is most effective and best tolerated? A. Chlorambucil B. Fludarabine C. Rituximab D. Ofatumumab E. Lenalidomide

More Related